Financial Counselors Inc’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-182,888
Closed -$30.3M 298
2025
Q1
$30.3M Buy
182,888
+13,957
+8% +$2.18M 0.46% 56
2024
Q4
$24.4M Sell
168,931
-16,162
-9% -$2.5M 0.36% 71
2024
Q3
$30M Buy
185,093
+9,309
+5% +$1.48M 0.44% 64
2024
Q2
$25.7M Sell
175,784
-7,589
-4% -$1.13M 0.41% 65
2024
Q1
$29M Buy
183,373
+22,943
+14% +$3.65M 0.49% 59
2023
Q4
$25.1M Sell
160,430
-7,174
-4% -$1.1M 0.45% 63
2023
Q3
$26.1M Buy
167,604
+160
+0.1% +$26.4K 0.52% 58
2023
Q2
$27.7M Sell
167,444
-288
-0.2% -$46.5K 0.56% 51
2023
Q1
$26M Buy
167,732
+155
+0.1% +$25K 0.56% 54
2022
Q4
$29.6M Buy
167,577
+717
+0.4% +$124K 0.66% 43
2022
Q3
$27.3M Sell
166,860
-1,522
-0.9% -$258K 0.67% 41
2022
Q2
$29.9M Buy
168,382
+12,107
+8% +$2.16M 0.7% 38
2022
Q1
$27.7M Buy
156,275
+5,415
+4% +$921K 0.57% 52
2021
Q4
$25.8M Sell
150,860
-26,252
-15% -$4.3M 0.53% 57
2021
Q3
$28.6M Buy
177,112
+2,691
+2% +$459K 0.61% 48
2021
Q2
$28.7M Sell
174,421
-1,422
-0.8% -$235K 0.62% 48
2021
Q1
$28.9M Sell
175,843
-1,283
-0.7% -$208K 0.67% 45
2020
Q4
$27.9M Sell
177,126
-5,879
-3% -$868K 0.7% 40
2020
Q3
$27.2M Sell
183,005
-22,491
-11% -$3.33M 0.8% 35
2020
Q2
$28.9M Buy
205,496
+64,476
+46% +$9.4M 0.92% 27
2020
Q1
$18.5M Buy
141,020
+1,037
+0.7% +$147K 0.82% 33
2019
Q4
$20.4M Sell
139,983
-1,212
-0.9% -$164K 0.73% 36
2019
Q3
$18.3M Buy
141,195
+1,348
+1% +$178K 0.72% 38
2019
Q2
$19.5M Buy
139,847
+97
+0.1% +$13.4K 0.79% 30
2019
Q1
$19.5M Buy
139,750
+2,296
+2% +$308K 0.83% 27
2018
Q4
$17.7M Sell
137,454
-6,769
-5% -$944K 0.87% 27
2018
Q3
$19.9M Sell
144,223
-5,616
-4% -$746K 0.87% 25
2018
Q2
$18.2M Buy
149,839
+1,555
+1% +$194K 0.84% 27
2018
Q1
$19M Sell
148,284
-2,707
-2% -$366K 0.9% 20
2017
Q4
$21.1M Sell
150,991
-6,175
-4% -$860K 0.97% 20
2017
Q3
$20.4M Sell
157,166
-1,480
-0.9% -$196K 1% 19
2017
Q2
$21M Sell
158,646
-701
-0.4% -$89.4K 1.04% 13
2017
Q1
$19.8M Sell
159,347
-3,176
-2% -$379K 1.01% 16
2016
Q4
$18.7M Buy
+162,523
New +$18.8M 1% 16
2016
Q2
$18.6M Buy
153,574
+3,611
+2% +$410K 1.11% 14
2016
Q1
$16.2M Buy
149,963
+1,837
+1% +$190K 1.01% 15
2015
Q4
$15.2M Buy
148,126
+328
+0.2% +$33K 0.98% 17
2015
Q3
$13.8M Buy
147,798
+1,397
+1% +$135K 0.95% 19
2015
Q2
$14.3M Sell
146,401
-2,850
-2% -$285K 0.91% 23
2015
Q1
$15M Buy
149,251
+4,605
+3% +$468K 0.93% 18
2014
Q4
$15.1M Buy
144,646
+4,880
+3% +$514K 0.96% 19
2014
Q3
$14.9M Buy
139,766
+2,689
+2% +$279K 1.05% 16
2014
Q2
$14.3M Sell
137,077
-306
-0.2% -$30.9K 1% 18
2014
Q1
$13.5M Buy
137,383
+1,597
+1% +$148K 0.97% 21
2013
Q4
$12.4M Buy
135,786
+1,348
+1% +$124K 0.93% 22
2013
Q3
$11.7M Sell
134,438
-9,405
-7% -$844K 0.96% 20
2013
Q2
$12.3M Buy
+143,843
New +$12.2M 1.03% 21

Other funds holding JNJ

Financial Counselors Inc's JNJ Position: Q2 2025 in Review

Financial Counselors Inc sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 182,888 shares — an estimated $30.3M sold.

Financial Counselors Inc first reported a position in JNJ in Q2 2013 and held it in 47 quarters. The position peaked at $30.3M in Q1 2025. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Financial Counselors Inc reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • Financial Counselors Inc sold 182,888 Johnson & Johnson shares in Q2 2025, an estimated $30.3M.
  • Financial Counselors Inc first reported a position in Johnson & Johnson in Q2 2013 and held it in 47 quarters.
  • Financial Counselors Inc's Johnson & Johnson position peaked at $30.3M in Q1 2025.
  • 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.